Compare SNPX & VINO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
Gaucho Group Holdings Inc develops and operates real estate projects in Argentina. It operates a hotel, golf and tennis resort, vineyard and producing winery in addition to developing residential lots located near the resort. The company operates in three segments which are the business of real estate development and manufacture; the sale of high-end fashion and accessories through an e-commerce platform; corporate operations. It derives majority of its revenue from the Real Estate Development segment.